Drug interactions
Armodafinil + Buprenorphine subdermal implant
Severity: Moderate
Armodafinil and Buprenorphine subdermal implant: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Armodafinil may lower buprenorphine concentrations. In patients with an implant, which cannot be titrated, this may cause withdrawal symptoms or loss of opioid dependence control.
What this interaction means in plain words
Armodafinil and Buprenorphine subdermal implant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Armodafinil induces CYP3A4, increasing buprenorphine metabolism.
What to do
Monitor for withdrawal signs and cravings; if they occur and armodafinil cannot be stopped, consider removing the implant and switching to an adjustable buprenorphine form.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Buprenorphine subdermal implant, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Armodafinil
Frequently asked questions
Can I take Armodafinil with Buprenorphine subdermal implant?
MediHelp rates the interaction as moderate. Armodafinil and Buprenorphine subdermal implant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Armodafinil may lower buprenorphine concentrations. In patients with an implant, which cannot be titrated, this may cause withdrawal symptoms or loss of opioid dependence control.
How serious is the interaction between Armodafinil and Buprenorphine subdermal implant?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for withdrawal signs and cravings; if they occur and armodafinil cannot be stopped, consider removing the implant and switching to an adjustable buprenorphine form.
What other medicines interact with Armodafinil?
MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
